![Liora Sklair-Tavron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Liora Sklair-Tavron
Direttore operativo presso Regentis Biomaterials Ltd.
Posizioni attive di Liora Sklair-Tavron
Società | Posizione | Inizio | Fine |
---|---|---|---|
Regentis Biomaterials Ltd.
![]() Regentis Biomaterials Ltd. BiotechnologyHealth Technology Regentis Biomaterials Ltd. engages in the research and development of proprietary hydrogels for local repair of damaged cartilage and bone. Its product is GelrinC. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel. | Direttore operativo | 01/03/2018 | - |
Storia della carriera di Liora Sklair-Tavron
Precedenti posizioni note di Liora Sklair-Tavron
Società | Posizione | Inizio | Fine |
---|---|---|---|
Bioblast Pharma Ltd.
![]() Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Consigliere Generale | 01/03/2015 | - |
Formazione di Liora Sklair-Tavron
Weizmann Institute of Science | Doctorate Degree |
Statistiche
Distribuzione geografica
Israele | 4 |
Posizioni
General Counsel | 1 |
Doctorate Degree | 1 |
Chief Operating Officer | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Bioblast Pharma Ltd.
![]() Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Health Technology |
Regentis Biomaterials Ltd.
![]() Regentis Biomaterials Ltd. BiotechnologyHealth Technology Regentis Biomaterials Ltd. engages in the research and development of proprietary hydrogels for local repair of damaged cartilage and bone. Its product is GelrinC. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel. | Health Technology |
- Borsa valori
- Insiders
- Liora Sklair-Tavron
- Esperienza